Minaris Advanced Testing offers comprehensive, GMP-compliant lot release testing for CHO cell–derived monoclonal antibody (mAb) products, supporting clinical development and commercial supply. Our integrated approach combines host cell impurity testing, orthogonal analytical platforms, potency bioassays, molecular identity, and compendial microbiological methods to ensure product safety, purity, strength, and consistency. Backed by decades of biosafety and biologics testing expertise, we deliver reliable, regulatory-ready data to help you release each lot with confidence.
Download the flyer to explore our full CHO mAb lot release testing capabilities and discover how Minaris can support your program from development through commercialization.
